METHOD FOR TREATING EGFR-TKI-RESISTANT NON-SMALL CELL LUNG CANCER BY ADMINISTRATION OF ANTI-HER3 ANTIBODY-DRUG CONJUGATE

• 收藏
• 分享

专利权人:

KINKI UNIVERSITY;DAIICHI SANKYO COMPANY, LIMITED

发明人:

Kimio YONESAKA,Kazuhiko NAKAGAWA,Kenji HIROTANI

申请号：

US16485777

公开号：

US20200061031A1

申请日:

2018.02.27

申请国别(地区):

US

年份:

2020

代理人:

摘要：

[Problem] To provide a therapeutic agent and a therapeutic method for EGFR-TKI-resistant non-small cell lung cancer.[Solution] Provided are: a therapeutic agent that contains an anti-HER3 antibody-drug conjugate as an active ingredient, or a therapeutic method characterized by administering an anti-HER3 antibody-drug conjugate.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/